Preclinical developer of an oral small molecule therapy for hemochromatosis.
Industry: Health Care
Latest Trade: $4.23 -0.01 (-0.2%)
First Day Return: -28.6%
Return from IPO: -39.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/14/2023 |
Offer Price | $7.00 |
Price Range $7.00 - $7.00 | |
Offer Shares (mm) | 1.0 |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/08/2024 |
Offer Price | $7.00 |
Price Range $7.00 - $7.00 | |
Offer Shares (mm) | 1.0 |
Deal Size ($mm) | $7 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Kingswood Capital Markets |
Company Data | |
---|---|
Headquarters | Baltimore, MD, United States |
Founded | 2021 |
Employees at IPO | 6 |
Website www.telomirpharma.com |